A novel benzenediamine derivate rescued mice from experimental sepsis by attenuating proinflammatory mediators via IRAK4

American Journal of Respiratory Cell and Molecular Biology

Volumn 51, Issue 2, 2014, Pages 191-200

  Dou, Huan ^a   Song, Yuxian ^a   Liu, Xianqin ^a   Yang, Liu ^a   Jiang, Nan ^b   Chen, Dai ^c   Li, Erguang ^a   Tan, Renxiang ^a   Hou, Yayi ^a  

^a NANJING UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c Novel Bioinformatics Company   (China)

Author keywords

FC 99; Inflammation; IRAK4; Macrophage; Sepsis

Indexed keywords

FC-99; INFLAMMATION; IRAK4; MACROPHAGE; SEPSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BENZENE DERIVATIVES; CELL LINE; DIAMINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MOLECULAR DOCKING SIMULATION; MOLECULAR STRUCTURE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN CONFORMATION; PROTEIN KINASE INHIBITORS; SEPSIS; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; TIME FACTORS;

EID: 84905496661     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2013-0411OC     Document Type: Article

References (43)

1. Locksley RM, Killeen N, Lenardo MJ. The tnf and tnf receptor superfamilies: integrating mammalian biology. Cell 2001;104:487-501.
2. Bjorkbacka H, Fitzgerald KA, Huet F, Li X, Gregory JA, Lee MA, Ordija CM, Dowley NE, Golenbock DT, Freeman MW. The induction of macrophage gene expression by lps predominantly utilizes myd88-independent signaling cascades. Physiol Genomics 2004;19:319-330.
3. Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 2007;65:S140-S146.
4. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 2006;83:456S-460S.
5. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-867.
6. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008;8:776-787.
7. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-150.
8. Tan RX, Zou WX. Endophytes: a rich source of functional metabolites. Nat Prod Rep 2001;18:448-459.
9. Cole RJ, Kirksey JW, Dorner JW, Wilson DM, Johnson JC Jr, Johnson AN, Bedell DM, Springer JP, Chexal KK, Clardy JC, et al. Mycotoxins produced by aspergillus fumigatus species isolated from molded silage. J Agric Food Chem 1977;25:826-830.
10. Zhao Y, Liu J, Wang J, Wang L, Yin H, Tan R, Xu Q. Fumigaclavine c improves concanavalin a-induced liver injury in mice mainly via inhibiting tnf-α production and lymphocyte adhesion to extracellular matrices. J Pharm Pharmacol 2004;56:775-782.
11. Wu X-F, Fei M-J, Shu R-G, Tan R-X, Xu Q. Fumigaclavine c, an fungal metabolite, improves experimental colitis in mice via downregulating th1 cytokine production and matrix metalloproteinase activity. Int Immunopharmacol 2005;5:1543-1553.
12. Bernard EM, Edwards FF, Kiehn TE, Brown ST, Armstrong D. Activities of antimicrobial agents against clinical isolates of mycobacterium haemophilum. Antimicrob Agents Chemother 1993;37:2323-2326.
13. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
14. Zheng Y, Lee S, Liang X, Wei S, Moon HG, Jin Y. Suppression of ptrf alleviates the polymicrobial sepsis induced by cecal ligation and puncture in mice. J Infect Dis 2013;208:1803-1812.
15. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010;11:373-384.
16. Baron RM, Baron MJ, Perrella MA. Pathobiology of sepsis: are we still asking the same questions? Am J Respir Cell Mol Biol 2006;34:129-134.
17. Institute of Laboratory Animal Resources; Commission on Life Sciences; National Research Council. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press; 1996 [accessed 2013 Sep. 28]. Available from: http://grants.Nih.Gov/grants/olaw/olaw.htm
18. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 2009;4:31-36.
19. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW III, Bland KI, Chaudry IH. Cecal ligation and puncture. Shock 2005;24:52-57.
20. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science 1999;284:1313-1318.
21. Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol 2002;20:825-852.
22. Guha M, Mackman N. Lps induction of gene expression in human monocytes. Cell Signal 2001;13:85-94.
23. da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: transfer from cd14 to tlr4 and md-2. J Biol Chem 2001;276:21129-21135.
24. Janssens S, Beyaert R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (irak) family members. Mol Cell 2003;11:293-302.
25. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990;113:227-242.
26. Netea MG, van der Meer JW, van Deuren M, Kullberg BJ. Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing? Trends Immunol 2003;24:254-258.
27. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001;2:108-115.
28. Stoll LL, Denning GM, Weintraub NL. Endotoxin, tlr4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease. Curr Pharm Des 2006;12:4229-4245.
29. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the drosophila toll protein signals activation of adaptive immunity. Nature 1997;388:394-397.
30. Dou H, Song Y, Liu X, Gong W, Li E, Tan R, Hou Y. Chaetoglobosin fex from the marine-derived endophytic fungus inhibits induction of inflammatory mediators via Toll-like receptor 4 signaling in macrophages. Biol Pharm Bull 2011;34:1864-1873.
31. Hume DA, Underhill DM, Sweet MJ, Ozinsky AO, Liew FY, Aderem A. Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state. BMC Immunol 2001;2:11.
32. Mata-Haro V, Cekic C, Martin M, Chilton PM, Casella CR, Mitchell TC. The vaccine adjuvant monophosphoryl lipid a as a trif-biased agonist of tlr4. Science 2007;316:1628-1632.
33. Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C, Takada H, Wakeham A, Itie A, Li S, et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking irak-4. Nature 2002;416:750-756.
34. Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K, Soudais C, Dupuis S, Feinberg J, Fieschi C, et al. Pyogenic bacterial infections in humans with irak-4 deficiency. Science 2003;299:2076-2079.
35. Kim TW, Staschke K, Bulek K, Yao J, Peters K, Oh KH, Vandenburg Y, Xiao H, Qian W, Hamilton T, et al. A critical role for irak4 kinase activity in Toll-like receptor-mediated innate immunity. J Exp Med 2007;204:1025-1036.
36. Lye E, Mirtsos C, Suzuki N, Suzuki S, Yeh WC. The role of interleukin 1 receptor-associated kinase-4 (irak-4) kinase activity in irak-4-mediated signaling. J Biol Chem 2004;279:40653-40658.
37. Lien E, Chow JC, Hawkins LD, McGuinness PD, Miyake K, Espevik T, Gusovsky F, Golenbock DT. A novel synthetic acyclic lipid a-like agonist activates cells via the lipopolysaccharide/toll-like receptor 4 signaling pathway. J Biol Chem 2001;276:1873-1880.
38. Lengauer T, Rarey M. Computational methods for biomolecular docking. Curr Opin Struct Biol 1996;6:402-406.
39. Karin M, Delhase M. The i kappa b kinase (ikk) and nf-kappa b: key elements of proinflammatory signalling. Semin Immunol 2000;12:85-98.
40. Barnes PJ, Karin M. Nuclear factor-kappab: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
41. Israel A. The ikk complex: an integrator of all signals that activate nfkappab? Trends Cell Biol 2000;10:129-133.
42. Chang L, Karin M. Mammalian map kinase signalling cascades. Nature 2001;410:37-40.
43. Pennini ME, Perkins DJ, Salazar AM, Lipsky M, Vogel SN. Complete dependence on irak4 kinase activity in tlr2, but not tlr4, signaling pathways underlies decreased cytokine production and increased susceptibility to streptococcus pneumoniae infection in irak4 kinaseinactive mice. J Immunol 2013;190:307-316.